SBA 7(a) Behavioral Health Feasibility Study in Texas

Texas treatment providers borrow above the national middle

Texas holds a rank of 5 among states in behavioral health and addiction treatment lending under this program, a top-five position that sits oddly beside the class's modest standing of 25 of 39 inside Texas itself: the state is large enough that even a small class piles up volume. The record holds 53 approvals adding up to $35.6 million. A median of $290,000 comes to 1.16x the national figure, so a Texas provider borrows somewhat more than peers elsewhere, and loans commonly land between $100,000 and $625,000. Franchising covers 26.4% of loans, a high share for a clinical trade. No distinctness basis is recorded; the cell stands out by rank, not by a ratio that clears our margin.

Holders spread across metros

The Huntington National Bank is credited with 11 loans but only $1.7 million, while Newtek Bank, National Association is credited with 6 loans and $6.3 million, a far heavier average. SBA's table names present holders, so a bank listed here may have acquired a loan it did not write. By county, Harris leads at 8, Bexar and Travis follow at 6 apiece, and Collin, Dallas and Tarrant at 4 apiece, so lending reaches every large metro as well as El Paso, Fort Bend, Galveston and Grayson at 3 apiece. Annual activity swung widely: 6 loans and $8.2 million in FY2017, a year with no approvals in FY2020, then 9 loans and $1.5 million in FY2023 and 8 loans and $8.3 million in FY2025.

Texas approvals up to FY2024 show a cancellation floor of 15.8%, the ceiling being identical, so this is among the higher figures a lender will see in a health class. Texas offers no charge-off rate here, because the earliest funded loans number too few for publication; the gap says nothing about loss experience, and it is not a claim of zero.

What a Texas study has to test

Both industry codes cover mental health care and addiction treatment together, which cannot be pulled apart, so the study must say which service line the borrower will run. Demand should be measured by population need in the catchment and by referral relationships, not by assumption. Licensing is a gate: state approval, accreditation and the credentials of clinical staff can delay opening, and the study should schedule that delay into the cash flow. Payer mix matters, since insurance contracts and reimbursement lag drive receivables. Staffing and clinician retention dominate expense. If the loan buys a building, expect the appraisal to price the property by its licensed use, and a lender will ask how the building could be reused. Coverage should be shown at a slow census and at full capacity, with the interval between them stated plainly.